clinical-ai
(16)
Andreas Cleve Is Building the Quiet Layer Beneath Healthcare AI
Long before the ambient-scribe rush, Andreas Cleve made a stubborn bet: the useful AI in a consultation would listen carefully, understand context and stay out of the way. A decade later, Corti is turning that bet into infrastructure.
Pelu Tran Left the White Coat for the Last Mile of AI
Four months from a Stanford MD, Pelu Tran chose a startup over a diploma. Two companies later, he is still working on the same stubborn problem: getting useful technology into the hands of clinicians without making their work harder.
Bobby Reddy Bet a Decade on the Data Hospitals Were Missing
An all-access hospital badge helped an electrical engineer discover that his clever device was solving the wrong problem. What followed was a ten-year lesson in listening, clinical rigor and the unglamorous patience required to make AI useful.
Elliott Green
Elliott Green is the co-founder and CEO of Dandelion Health, a New York-based real-world data and clinical AI platform building multimodal, longitudinal datasets from a consortium of non-academic health systems. A former founding member of Oscar Health with a finance background, Green launched Dandelion in 2020 to give life science companies and AI developers unbiased, clinical-grade data - including the images, waveforms, and notes that make up most of medicine but are rarely used. The company closed a $14M Series A in 2026 and has launched a free AI validation service and a GLP-1 data library aimed at bringing precision medicine to cardiometabolic disease.
Maria Manso
Maria Manso is the co-founder and CEO of Tucuvi, a Madrid-based healthtech company that builds LOLA, a clinical-grade voice AI agent used by more than 60 healthcare organizations to conduct automated patient follow-up calls. A biomedical engineer by training, she has raised over $21 million for the company, including a $20 million Series A round in January 2026, and was named to the Forbes 30 Under 30 Europe 2025 list for Science & Healthcare.
Sanchit Mullick
Sanchit Mullick is the co-founder and CEO of Reveal HealthTech, a New York-based AI transformation firm for U.S. healthcare and life sciences that closed a $7.2M Series A led by Leo Capital in September 2025. Before Reveal, he spent nearly two decades at Infosys, ending as global head of sales for AI & Automation, then led private-equity sales at GlobalLogic. He built Reveal in 2023 with clinician Dr. Salim Afshar and Andrew Bravo, incubated by W Health Ventures and 2070 Health, around two products: BioCanvas for multimodal clinical AI and Prism AI for workflow agents.
Nicolas Abad
Nicolas Abad is the co-founder and CEO of Telepatia, a Latin American healthtech company building AI healthcare workers - starting with an 'AI Doctor' that transcribes consultations, reviews records, flags drug interactions, and surfaces clinical guidance in real time. Named after his late father's nickname, the company grew from a Stanford MBA side obsession to a venture backed by Andreessen Horowitz, reaching more than 14 million patients across five countries inside its first year. Abad's stated ambition is audacious to the point of comedy: win Latin America's first Nobel Prize in Medicine since 1984 by turning healthcare from scarcity into abundance.
David Stoffel
David Stoffel is the Chief Business Officer of RapidAI, the clinical-AI company whose stroke-imaging algorithms helped rewrite the rules of how strokes get treated. A medical doctor who chose boardrooms over bedsides, he has spent more than two decades turning ambitious medical technologies into standards of care - from the da Vinci surgical robot at Intuitive Surgical to mobile cardiac telemetry at iRhythm and point-of-care EEG at Ceribell. At RapidAI he runs the commercial engine: marketing, clinical affairs, education, customer success, corporate development, and finance.
Justin Norden
Justin Norden is the co-founder and CEO of Qualified Health, an enterprise AI platform helping U.S. health systems deploy generative AI safely, with governance, monitoring, and clinical safeguards built in. A Stanford-trained physician with an MBA, an MPhil in computational biology from Cambridge, and a computer science degree from Carleton, he previously was a partner at GSR Ventures investing in healthcare AI, founded Trustworthy AI (acquired by Waymo), worked on Apple's healthcare team, and teaches AI in medicine at Stanford. In March 2026 Qualified Health raised a $125M Series B led by NEA, bringing total funding to $155M while serving 500,000+ users across systems representing roughly 7% of U.S. hospital revenue.
Brent Dover
Brent Dover is the CEO of Carta Healthcare, an AI-powered clinical data management platform that serves hospitals and health systems nationwide using a 'Hybrid Intelligence' model combining AI with human expert abstractors. With over 20 years of healthcare technology leadership, Dover has presided over company-defining exits and growth events - including leading Medicity to a $500M acquisition by Aetna generating 16x investor returns, scaling Health Catalyst toward a NASDAQ IPO, and growing Commure to a $3.5B valuation. He joined Carta Healthcare in December 2023 and has since driven 2x revenue growth, 100% customer retention, and a $18.25M Series B1 round led by UPMC Enterprises.
Karim Karti
Karim Karti is the CEO of RapidAI, a deep clinical AI company whose platform is used in 2,500+ hospitals across 100+ countries for stroke, vascular, and radiology workflows. He brings 22+ years from GE Healthcare — including running its $9B imaging division — and a stint as COO of iRhythm, where he doubled revenues to $210M in 18 months. Trained as an engineer in France and a former P&G brand manager, he now leads one of the most clinically validated AI platforms in medicine, backed by 700+ published studies and 10+ million scans processed.
Punit Soni
Punit Singh Soni is the founder and CEO of Suki, the ambient clinical intelligence platform that lets doctors spend more time with patients and less time typing into electronic health records. A product veteran who helped ship the Moto X and rebuild Flipkart's consumer experience, Soni founded Suki in 2017 on a single thesis - 'AI is the new UI' - before that phrase became a conference staple. Suki now serves 350+ health systems across the US, has raised $255 million in total funding, and helps clinicians complete notes 72% faster. Soni was educated at NIT Kurukshetra, the University of Wyoming, and Wharton, and has lived at the intersection of big tech, emerging markets, and healthcare for over two decades.
Chris Mansi
Chris Mansi is a Cambridge and UCL-trained neurosurgeon turned AI entrepreneur, and the Co-founder and CEO of Viz.ai - the company that puts an AI brain between a CT scanner and a surgeon so that patients who are about to die of a stroke stop dying from delays. Named to TIME100 AI in 2024, Mansi built Viz.ai from a Stanford dorm-room insight into a platform covering nearly 2,000 U.S. hospitals and 230 million lives, reducing stroke diagnostic timelines by more than an hour - one patient at a time, every ten seconds.
Eduardo Reis
Dr. Eduardo Pontes Reis, MD is Vice President of Strategy in the Office of the CEO at Hippocratic AI, a Palo Alto-based generative AI healthcare company with $439M in total funding. A neuroradiologist and AI researcher, he bridges clinical medicine and artificial intelligence through leadership roles at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Hospital Israelita Albert Einstein in Brazil, where he initiated the Health Story medical timeline platform and led AI development for diseases including tuberculosis, COVID-19, melanoma, and head CT analysis. He co-authored the BRAX Brazilian Chest X-ray Dataset published in Nature Scientific Data, built open-source tools for integrating AI plugins into LLMs (plugnplai, 228+ GitHub stars), and served as Founding Radiologist at Cognita Imaging — a Stanford AIMI spinoff acquired by Radiology Partners for $80M — before joining Hippocratic AI in early 2026.
Harpreet Mangat
Harpreet Mangat is a British-trained neurosurgeon turned Stanford MBA and McKinsey consultant who now serves as Chief Strategy Officer and Chief of Staff to the CEO at Hippocratic AI, a $3.5 billion healthcare AI company building clinically safe generative AI agents for patient engagement. His rare career arc - from brain surgery and ICU care during COVID-19, through venture capital and management consulting, to the frontier of healthcare AI - makes him one of the most credentialed operator-clinicians in the industry.
Paxton Maeder-York
Paxton Maeder-York is the founder of Alife Health, an AI platform for IVF clinics that has raised $31.5M and raised the standard for data-driven fertility care. A Harvard-trained biomedical engineer and MBA, he previously helped build surgical robotics at Auris Health (acquired by J&J for $3.4B) and worked in product at Google X. In 2020, driven in part by the fact that his younger brother is an IVF baby, he founded Alife to apply machine learning to embryo selection, hormone dosing, and lab scheduling. By 2024 the company had launched five products, earned recognition from Fast Company and the World Economic Forum, and achieved a leadership transition - Paxton stepping into a board role as Melissa Teran took the CEO seat.